Biotechnology company developing next-generation, off-the-shelf cell therapies aimed at delivering affordable and scalable treatments for cancer and rare diseases. Based at the Babraham Research Campus near Cambridge, UK, the company combines expertise in gene editing, stem cell programming, and cellular engineering to create advanced cellular medicines with enhanced disease-fighting capabilities. Empyrean is building a proprietary platform of technologies, cellular assets, and manufacturing processes designed to rapidly produce novel therapeutic cell products, with the goal of expanding access to transformative treatments worldwide